Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Dexcom (DXCM) Profit After Tax (2016 - 2025)

Dexcom (DXCM) has disclosed Profit After Tax for 16 consecutive years, with $267.3 million as the latest value for Q4 2025.

  • On a quarterly basis, Profit After Tax rose 76.2% to $267.3 million in Q4 2025 year-over-year; TTM through Dec 2025 was $836.3 million, a 45.14% increase, with the full-year FY2025 number at $836.3 million, up 45.14% from a year prior.
  • Profit After Tax was $267.3 million for Q4 2025 at Dexcom, down from $283.8 million in the prior quarter.
  • In the past five years, Profit After Tax ranged from a high of $283.8 million in Q3 2025 to a low of $42.8 million in Q4 2021.
  • A 5-year average of $127.2 million and a median of $110.6 million in 2023 define the central range for Profit After Tax.
  • Peak YoY movement for Profit After Tax: plummeted 89.59% in 2021, then surged 201.23% in 2024.
  • Dexcom's Profit After Tax stood at $42.8 million in 2021, then skyrocketed by 114.49% to $91.8 million in 2022, then soared by 179.19% to $256.3 million in 2023, then crashed by 40.81% to $151.7 million in 2024, then surged by 76.2% to $267.3 million in 2025.
  • Per Business Quant, the three most recent readings for DXCM's Profit After Tax are $267.3 million (Q4 2025), $283.8 million (Q3 2025), and $179.8 million (Q2 2025).